Ftse Mib
37.121,77
1,48%
DAX
21.902,42
1,63%
S&P 500
6.083,57
0,36%
NASDAQ
19.791,99
0,51%
Bitcoin
97.448,26
0,90%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Seres Therapeutics Inc (MCRB) Seres Therapeutics Inc (MCRB) Notizie

Seres Therapeutics Inc

MCRB
0,8199
0,0294 (3,72%)
07 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/2/202514:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202514:00EDGAR2Form 8-K - Current report
06/2/202514:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/1/202513:00GLOBESeres Therapeutics Announces Receipt of Expected $50 Million..
13/1/202514:06EDGAR2Form 8-K - Current report
10/1/202513:00EDGAR2Form 8-K - Current report
09/1/202513:00GLOBESeres Therapeutics Announces New Translational Biomarker..
16/12/202413:00GLOBESeres Therapeutics to Participate in 2025 J.P. Morgan..
09/12/202413:00GLOBEFDA Grants Breakthrough Therapy Designation to Seres..
22/11/202413:00GLOBESeres Therapeutics to Participate in Piper Sandler..
19/11/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/11/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/11/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202416:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202414:05EDGAR2Form 8-K - Current report
13/11/202413:00GLOBESeres Therapeutics Reports Third Quarter 2024 Financial..
06/11/202413:00GLOBESeres Therapeutics to Announce Third Quarter 2024 Financial..
29/10/202423:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/10/202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/10/202423:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/10/202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202422:34EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
01/10/202422:46EDGAR2Form S-3 - Registration statement under Securities Act of..
01/10/202422:05EDGAR2Form 8-K - Current report
30/9/202423:15GLOBESeres Therapeutics Announces Completion of VOWST™ Asset Sale..
26/9/202422:13EDGAR2Form 8-K - Current report
26/9/202422:01GLOBESeres Therapeutics Stockholders Approve Sale of VOWST™ to..
13/9/202413:00GLOBESeres Therapeutics to Participate in Cantor 2024 Global..
12/9/202414:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/9/202413:05EDGAR2Form 8-K - Current report
12/9/202413:00GLOBESeres Therapeutics Reports SER-155 Phase 1b..
26/8/202422:36EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
19/8/202423:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202423:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202423:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202423:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202422:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
15/8/202412:52EDGAR2Form PREM14A - Preliminary proxy statements relating to..
15/8/202412:05EDGAR2Form 8-K - Current report
13/8/202423:21EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
13/8/202416:38EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202413:08EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
13/8/202413:05EDGAR2Form 8-K - Current report
13/8/202413:00GLOBESeres Therapeutics Reports Second Quarter 2024 Financial..
07/8/202414:38EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/8/202423:28EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/8/202423:28EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/8/202423:27EDGAR2Form 8-K - Current report
06/8/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 0,78 Min: 0,78 Max: 0,835
Chiusura: 0,7905

La tua Cronologia

NASDAQ
MCRB
Seres Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci